Differently lasting effects of prenatal and postnatal chronic clozapine/haloperidol on activity and memory in mouse offspring

Pharmacology Biochemistry and Behavior

Volumn 84, Issue 3, 2006, Pages 468-478

  Wang, Jian Hong ^a,b   Yang, Jian Zhen ^a   Wilson, Fraser A W ^a   Ma, Yuan Ye ^a  

^a KUNMING INSTITUTE OF ZOOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Clozapine; Haloperidol; Offspring; Open field; Step through; Water maze

Indexed keywords

CLOZAPINE; HALOPERIDOL; SCOPOLAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DEVELOPMENT; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HYPERACTIVITY; LONG TERM MEMORY; MALE; MAZE TEST; MEMORY; MEMORY DISORDER; MOUSE; NONHUMAN; OPEN FIELD TEST; PREGNANCY; PRIORITY JOURNAL; PROGENY; SPATIAL MEMORY;

ANIMALS; ANTIPSYCHOTIC AGENTS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BODY WEIGHT; CENTRAL NERVOUS SYSTEM; CLOZAPINE; FEMALE; HALOPERIDOL; MALE; MATERNAL EXPOSURE; MAZE LEARNING; MEMORY; MICE;

EID: 33747880935     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2006.06.010     Document Type: Article

References (58)

1. Abdul-Monim Z., Reynolds G.P., and Neill J.C. The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat. J Psychopharmacol 17 (2003) 57-65
2. Alberch J., Brito B., Notario V., and Castro R. Prenatal haloperidol treatment decreases nerve growth factor receptor and mRNA in neonate rat forebrain. Neurosci Lett 131 (1991) 228-232
3. Andersen S.L., and Gazzara R.A. Effects of (-)-sulpiride on dopamine release in striatum of developing rats: degree of depolarization influences responsiveness. J Neurochem 67 (1996) 1931-1937
4. Archer J. Tests for emotionality in rats and mice: a review. Anim Behav 21 (1973) 205-235
5. Arnt J., and Skarsfeldt T. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology 18 (1998) 63-101
6. Backhouse B., Barochovsky O., Malik C., Patel A.J., and Lewis P.D. Effects of haloperidol on cell proliferation in the early postnatal rat brain. Neuropathol Appl Neurobiol 8 (1982) 109-116
7. Baldessarini R.J., Centorrino F., Flood J.G., Volpicelli S.A., Huston-Lyons D., and Cohen B.M. Tissue concentrations of clozapine and its metabolites in the rat. Neuropsychopharmacology 9 (1993) 117-124
8. Baratti C.M., Introini I.B., Huygens P., and Gusovsky F. Possible cholinergic-dopaminergic link in memory facilitation induced by oxotremorine in mice. Psychopharmacology (Berl) 80 (1983) 161-165
9. Bilder R.M., Goldman R.S., Volavka J., Czobor P., Hoptman M., Sheitman B., et al. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am J Psychiatry 159 (2002) 1018-1028
10. Brunello N., Masotto C., Steardo L., Markstein R., and Racagni G. New insights into the biology of schizophrenia through the mechanism of action of clozapine. Neuropsychopharmacology 13 (1995) 177-213
11. Chung Y.C., Li Z., Dai J., Meltzer H.Y., and Ichikawa J. Clozapine increases both acetylcholine and dopamine release in rat ventral hippocampus: role of 5-HT1A receptor agonism. Brain Res 1023 (2004) 54-63
12. De Vries T.J., Mulder A.H., and Schoffelmeer A.N. Differential ontogeny of functional dopamine and muscarinic receptors mediating presynaptic inhibition of neurotransmitter release and postsynaptic regulation of adenylate cyclase activity in rat striatum. Brain Res Dev Brain Res 66 (1992) 91-96
13. Eastwood S.L., Heffernan J., and Harrison P.J. Chronic haloperidol treatment differentially affects the expression of synaptic and neuronal plasticity-associated genes. Mol Psychiatry 2 (1997) 322-329
14. Farde L., and Nordstrom A.L. PET analysis indicates atypical central dopamine receptor occupancy in clozapine-treated patients. Br J Psychiatry Suppl (1992) 30-33
15. Farde L., Hall H., Ehrin E., and Sedvall G. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science 231 (1986) 258-261
16. Fox C.A., Mansour A., and Watson Jr. S.J. The effects of haloperidol on dopamine receptor gene expression. Exp Neurol 130 (1994) 288-303
17. Gallhofer B., Bauer U., Lis S., Krieger S., and Gruppe H. Cognitive dysfunction in schizophrenia: comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs. Eur Neuropsychopharmacol 6 Suppl 2 (1996) S13-S20
18. Gemperle A.Y., McAllister K.H., and Olpe H.R. Differential effects of iloperidone, clozapine, and haloperidol on working memory of rats in the delayed non-matching-to-position paradigm. Psychopharmacology (Berl) 169 (2003) 354-364
19. Gilbertson M.W., and van Kammen D.P. Recent and remote memory dissociation: medication effects and hippocampal function in schizophrenia. Biol Psychiatry 42 (1997) 585-595
20. Hagger C., Buckley P., Kenny J.T., Friedman L., Ubogy D., and Meltzer H.Y. Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biol Psychiatry 34 (1993) 702-712
21. Hedner T., and Lundborg P. Development of dopamine autoreceptors in the postnatal rat brain. J Neural Transm 62 (1985) 53-63
22. Hill H.F., and Engblom J. Effects of pre- and postnatal haloperidol administrations to pregnant and nursing rats on brain catecholamine levels in their offspring. Dev Pharmacol Ther 7 (1984) 188-197
23. Ichihara K., Nabeshima T., and Kameyama T. Effects of haloperidol, sulpiride and SCH 23390 on passive avoidance learning in mice. Eur J Pharmacol 151 (1988) 435-442
24. Ichikawa J., Dai J., and Meltzer H.Y. 5-HT(1A) and 5-HT(2A) receptors minimally contribute to clozapine-induced acetylcholine release in rat medial prefrontal cortex. Brain Res 939 (2002) 34-42
25. Imperato A., Obinu M.C., and Gessa G.L. Is in vivo striatal acetylcholine output under a tonic inhibitory control by dopamine?. J Neural Transm Suppl 45 (1995) 91-102
26. Johnson D.E., Nedza F.M., Spracklin D.K., Ward K.M., Schmidt A.W., Iredale P.A., et al. The role of muscarinic receptor antagonism in antipsychotic-induced hippocampal acetylcholine release. Eur J Pharmacol 506 (2005) 209-219
27. Keefe R.S., Seidman L.J., Christensen B.K., Hamer R.M., Sharma T., Sitskoorn M.M., et al. Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol. Am J Psychiatry 161 (2004) 985-995
28. Lang A., Vasar E., Soosaar A., and Harro J. The involvement of sigma and phencyclidine receptors in the action of antipsychotic drugs. Pharmacol Toxicol 71 (1992) 132-138
29. Le W.D., Bostwick J.R., and Appel S.H. Use of [3H]-GBR12935 to measure dopaminergic nerve terminal growth into the developing rat striatum. Brain Res Dev Brain Res 67 (1992) 375-377
30. Leysen J.E., Janssen P.M., Schotte A., Luyten W.H., and Megens A.A. Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors. Psychopharmacology (Berl) 112 (1993) S40-S54
31. Lin M.Y., and Walters D.E. Dopamine D2 autoreceptors in rats are behaviorally functional at 21 but not 10 days of age. Psychopharmacology (Berl) 114 (1994) 262-268
32. Meltzer H.Y. Presynaptic receptors. Relevance to psychotropic drug action in man. Ann NY Acad Sci 604 (1990) 353-371
33. Meltzer H.Y., and McGurk S.R. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr Bull 25 (1999) 233-255
34. Meltzer H.Y., Bastani B., Ramirez L., and Matsubara S. Clozapine: new research on efficacy and mechanism of action. Eur Arch Psychiatry Neurol Sci 238 (1989) 332-339
35. Moran-Gates T., Gan L., Park Y.S., Zhang K., Baldessarini R.J., and Tarazi F.I. Repeated antipsychotic drug exposure in developing rats: dopamine receptor effects. Synapse 59 (2006) 92-100
36. Ninan I., and Kulkarni S.K. Clozapine-induced cognitive dysfunction in mice. Methods Find Exp Clin Pharmacol 18 (1996) 367-372
37. Olney J.W., and Farber N.B. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52 (1995) 998-1007
38. Ploeger G.E., Spruijt B.M., and Cools A.R. Effects of haloperidol on the acquisition of a spatial learning task. Physiol Behav 52 (1992) 979-983
39. Prado-Alcala R.A., Grinberg Z.J., Arditti Z.L., Garcia M.M., Prieto H.G., and Brust-Carmona H. Learning deficits produced by chronic and reversible lesions of the corpus striatum in rats. Physiol Behav 15 (1975) 283-287
40. Rogue P., Hanauer A., Zwiller J., Malviya A.N., and Vincendon G. Up-regulation of dopamine D2 receptor mRNA in rat striatum by chronic neuroleptic treatment. Eur J Pharmacol 207 (1991) 165-168
41. Rosengarten H., and Friedhoff A.J. Enduring changes in dopamine receptor cells of pups from drug administration to pregnant and nursing rats. Science 203 (1979) 1133-1135
42. Rosengarten H., and Quartermain D. The effect of chronic treatment with typical and atypical antipsychotics on working memory and jaw movements in three- and eighteen-month-old rats. Prog Neuropsychopharmacol Biol Psychiatry 26 (2002) 1047-1054
43. Scalzo F.M., and Spear L.P. Chronic haloperidol during development attenuates dopamine autoreceptor function in striatal and mesolimbic brain regions of young and older adult rats. Psychopharmacology (Berl) 85 (1985) 271-276
44. Scalzo F.M., Holson R.R., Gough B.J., and Ali S.F. Neurochemical effects of prenatal haloperidol exposure. Pharmacol Biochem Behav 34 (1989) 721-725
45. Schotte A., Janssen P.F., Gommeren W., Luyten W.H., Van Gompel P., Lesage A.S., et al. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology (Berl) 124 (1996) 57-73
46. Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1 (1987) 133-152
47. Shalaby I.A., and Spear L.P. Chronic administration of haloperidol during development: later psychopharmacological responses to apomorphine and arecoline. Pharmacol Biochem Behav 13 (1980) 685-690
48. Shalaby I.A., and Spear L.P. Psychopharmacological effects of low and high doses of apomorphine during ontogeny. Eur J Pharmacol 67 (1980) 451-459
49. Sharma T. Cognitive effects of conventional and atypical antipsychotics in schizophrenia. Br J Psychiatry Suppl (1999) 44-51
50. Sharma T., Hughes C., Soni W., and Kumari V. Cognitive effects of olanzapine and clozapine treatment in chronic schizophrenia. Psychopharmacology (Berl) 169 (2003) 398-403
51. Skarsfeldt T. Differential effect of antipsychotics on place navigation of rats in the Morris water maze. A comparative study between novel and reference antipsychotics. Psychopharmacology (Berl) 124 (1996) 126-133
52. Stip E., Chouinard S., and Boulay L.J. On the trail of a cognitive enhancer for the treatment of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005) 219-232
53. Tandon R., and Jibson M.D. Extrapyramidal side effects of antipsychotic treatment: scope of problem and impact on outcome. Ann Clin Psychiatry 14 (2002) 123-129
54. Terry Jr. A.V., Hill W.D., Parikh V., Evans D.R., Waller J.L., and Mahadik S.P. Differential effects of chronic haloperidol and olanzapine exposure on brain cholinergic markers and spatial learning in rats. Psychopharmacology (Berl) 164 (2002) 360-368
55. Wang J., Cai J., and Guan L. Effects of pyrolidinone-2 compounds on the learning and memory in water-maze test in mice. Acta Psychologica Sinica 29 (1997) 53-58
56. Williams R., Ali S.F., Scalzo F.M., Soliman K., and Holson R.R. Prenatal haloperidol exposure: effects on brain weights and caudate neurotransmitter levels in rats. Brain Res Bull 29 (1992) 449-458
57. Wolff M.C., and Leander J.D. Comparison of the effects of antipsychotics on a delayed radial maze task in the rat. Psychopharmacology (Berl) 168 (2003) 410-416
58. Xu S.X., Monsma Jr. F.J., Sibley D.R., and Creese I. Regulation of D1A and D2 dopamine receptor mRNA during ontogenesis, lesion and chronic antagonist treatment. Life Sci 50 (1992) 383-396